Survey: U.S. patient groups have low opinion of drugmaker marketing ethics

04/8/2013 |

Half of 70 U.S.-based patient groups surveyed said drugmakers are innovative, and 59% said drugmakers are good or excellent at creating high-quality, useful products. But 76% said drugmakers have fair or poor ethics in marketing, and only 10% said the industry is transparent. In the U.K., 70% of 80 patient groups surveyed rated drugmakers as good or excellent at making high-quality, useful products and 72% rated ethics in industry marketing as fair or poor.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC